BactiQuant AS (FRA:9JX) Total Equity: €2.31 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:9JX BactiQuant AS FRA:9JX
56 GF Score
Price €0.29
GF Value €0.27
! 4 Warning Signs
View Full Analysis

What is BactiQuant AS Total Equity?

BactiQuant AS FRA:9JX +2.15% 56 Total Equity is €2.31 Mil as of Dec. 2025. GuruFocus rates FRA:9JX with a GF Score™ of 56/100 and a GF Value™ of €0.27. The stock has 4 warning signs investors should review.

BactiQuant AS's total equity for the quarter that ended in Dec. 2025 was €2.31 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


BactiQuant AS Total Equity Historical Data

* Premium members only.

The historical data trend for BactiQuant AS's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BactiQuant AS Total Equity Chart

BactiQuant AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial 2.83 1.92 1.93 0.09 2.31

BactiQuant AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.93 0.92 0.09 1.07 2.31
FRA:9JX
56GF Score
BactiQuant AS FRA:9JX
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BactiQuant AS Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

BactiQuant AS's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=3.758-1.447
=2.31

BactiQuant AS's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=3.758-1.447
=2.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €2.31 Mil mean?
BactiQuant AS (FRA:9JX) has a Total Equity of €2.31 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for BactiQuant AS and its competitors.
Is BactiQuant AS's Total Equity too high?
BactiQuant AS's current Total Equity is €2.31 Mil. Overall, BactiQuant AS has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does BactiQuant AS's Total Equity compare to VLTO and ZWS?
BactiQuant AS's Total Equity of €2.31 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for an Industrial Products company?
A good Total Equity depends on the Industrial Products industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for BactiQuant AS and its competitors. BactiQuant AS's current Total Equity is €2.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BactiQuant AS stock overvalued right now?
BactiQuant AS (FRA:9JX) has a current Total Equity of €2.31 Mil. The stock's GF Value™ is €0.27, compared to a current price of €0.29 — trading 5.6% above its estimated fair value. The current Total Equity is €2.31 Mil. BactiQuant AS's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For BactiQuant AS (FRA:9JX), the current Total Equity is €2.31 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BactiQuant AS (FRA:9JX) Overvalued in 2026?

Based on GuruFocus' analysis, BactiQuant AS stock appears to be overvalued. The current stock price of €0.29 is trading 5.6% above its estimated GF Value™ of €0.27.

Key valuation signals for FRA:9JX:

  • Total Equity: €2.31 Mil
  • GF Value™: €0.27 vs. price of €0.29 (5.6% above fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the FRA:9JX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BactiQuant AS Business Description

Other Exchanges BACTIQ:Denmark
Address Blokken 75, Birkeroed, DNK, DK-3460
BactiQuant AS focuses on delivering technology that ensures optimum usage and handling of water around the world. The company's activities include the development, production, sale and service of BactiQuant Online and BactiQuant Mobile Lab with associated test kits/substrate for the quantification and detection of bacteria in water. Its segments are Aquaculture, Data Centres, Oil & Gas, Water Utility, Industry, and Pharma. The group's products are BQ Online 2.0 PRO, BQ Online, BQ Mobile Lab, and Analysis Kits.
56GF Score

Get the complete analysis for FRA:9JX

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.29
Price
€0.27
GF Value